Hypertensive Treatment Pattern Survey for Type II Diabetes Mellitus Patients With Complication and Hypertension

AstraZeneca2,000 enrolled

Overview

This study will address the treatment rate and control rate of hypertension, treatment pattern and factors to affect blood pressure control by examining (retrospective) medical records of Type II DM patients with DM related complication and hypertension, among outpatients coming to the Endocrinology Department in 20 general hospital settings nationwide.

Study Type

OBSERVATIONAL

Enrollment

2,000

Conditions

Hypertension

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * After diagnosed type II DM, patients received treatment for a least 3 years * Type II DM patients with hypertension and its complication. * Visited out-patients to care center after 1 Jan. 2008 Exclusion Criteria: * Secondary hypertension patients * Patients not receiving hypertension medication * Patients stopping BP medication, by physician's order * Patients currently enrolled in other clinical studies

Locations (13)

Research Site

Wŏnju, Gangwon-do, South Korea

Research Site

Bucheon-si, Gyeonggi-do, South Korea

Research Site

Goyang-si, Gyeonggi-do, South Korea

Outcomes

Primary Outcomes

Attainment rate to the target blood pressure.

Time frame: After collecting all Patient Record Form.

Secondary Outcomes

Attainment to the target blood pressure will be investigated according to DM related complications.

Time frame: After collecting all Patient Record Form.

Change in the DBP/SBP value will be investigated according to the DM Complication

Time frame: After collecting all Patient Record Form.

Treatment pattern and factors that affect BP control

Time frame: After collecting all Patient Record Form.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.